A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
15 06 2021
Historique:
received: 27 07 2020
accepted: 28 10 2020
pubmed: 30 10 2020
medline: 15 2 2022
entrez: 29 10 2020
Statut: ppublish

Résumé

Spontaneous clearance of acute hepatitis C virus (HCV) infection is more common in women than in men, independent of known risk factors. To identify sex-specific genetic loci, we studied 4423 HCV-infected individuals (2903 male, 1520 female) of European, African, and Hispanic ancestry. We performed autosomal, and X chromosome sex-stratified and combined association analyses in each ancestry group. A male-specific region near the adenosine diphosphate-ribosylation factor-like 5B (ARL5B) gene was identified. Individuals with the C allele of rs76398191 were about 30% more likely to have chronic HCV infection than individuals with the T allele (OR, 0.69; P = 1.98 × 10-07), and this was not seen in females. The ARL5B gene encodes an interferon-stimulated gene that inhibits immune response to double-stranded RNA viruses. We also identified suggestive associations near septin 6 and ribosomal protein L39 genes on the X chromosome. In box sexes, allele G of rs12852885 was associated with a 40% increase in HCV clearance compared with the A allele (OR, 1.4; P = 2.46 × 10-06). Septin 6 facilitates HCV replication via interaction with the HCV NS5b protein, and ribosomal protein L39 acts as an HCV core interactor. These novel gene associations support differential mechanisms of HCV clearance between the sexes and provide biological targets for treatment or vaccine development.

Sections du résumé

BACKGROUND
Spontaneous clearance of acute hepatitis C virus (HCV) infection is more common in women than in men, independent of known risk factors.
METHODS
To identify sex-specific genetic loci, we studied 4423 HCV-infected individuals (2903 male, 1520 female) of European, African, and Hispanic ancestry. We performed autosomal, and X chromosome sex-stratified and combined association analyses in each ancestry group.
RESULTS
A male-specific region near the adenosine diphosphate-ribosylation factor-like 5B (ARL5B) gene was identified. Individuals with the C allele of rs76398191 were about 30% more likely to have chronic HCV infection than individuals with the T allele (OR, 0.69; P = 1.98 × 10-07), and this was not seen in females. The ARL5B gene encodes an interferon-stimulated gene that inhibits immune response to double-stranded RNA viruses. We also identified suggestive associations near septin 6 and ribosomal protein L39 genes on the X chromosome. In box sexes, allele G of rs12852885 was associated with a 40% increase in HCV clearance compared with the A allele (OR, 1.4; P = 2.46 × 10-06). Septin 6 facilitates HCV replication via interaction with the HCV NS5b protein, and ribosomal protein L39 acts as an HCV core interactor.
CONCLUSIONS
These novel gene associations support differential mechanisms of HCV clearance between the sexes and provide biological targets for treatment or vaccine development.

Identifiants

pubmed: 33119750
pii: 5943036
doi: 10.1093/infdis/jiaa677
pmc: PMC8205624
doi:

Substances chimiques

Ribosomal Proteins 0
ribosomal protein L39 0
Septins EC 3.6.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2090-2098

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI066345
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035040
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035041
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024996
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA013324
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035043
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA021550
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035042
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025005
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI082630
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI031834
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD041224
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL076902
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148049
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI131314
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035039
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA036297
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034989
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034993
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016159
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034994
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035004
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD032632
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI042590
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI088791
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

J Virol. 2013 May;87(10):5718-31
pubmed: 23487458
Ann Hum Genet. 2015 Mar;79(2):136-47
pubmed: 25644736
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176
pubmed: 28404132
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
PLoS One. 2014 Dec 05;9(12):e113684
pubmed: 25479423
Jpn J Infect Dis. 2015;68(2):81-8
pubmed: 25420655
Trends Cell Biol. 1999 Oct;9(10):387-94
pubmed: 10481176
J Pathol. 2004 Nov;204(4):489-505
pubmed: 15495264
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
J Viral Hepat. 2006 Jan;13(1):34-41
pubmed: 16364080
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
J Pathol. 2005 Jul;206(3):269-78
pubmed: 15915442
Biol Sex Differ. 2019 Dec 9;10(1):57
pubmed: 31818333
J Hered. 2015 Sep-Oct;106(5):666-71
pubmed: 26268243
J Biol Chem. 2015 Jan 9;290(2):1269-80
pubmed: 25451939
Cell. 2018 Nov 29;175(6):1701-1715.e16
pubmed: 30449622
J Biomed Sci. 2014 Aug 19;21:71
pubmed: 25135111
Arch Virol. 2016 Mar;161(3):641-8
pubmed: 26660164
Gastroenterology. 2019 Apr;156(5):1496-1507.e7
pubmed: 30593799
Science. 2007 Jun 1;316(5829):1341-5
pubmed: 17463248
Am J Hum Genet. 2018 Apr 5;102(4):592-608
pubmed: 29606303
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Genes Immun. 2014 Apr;15(4):241-6
pubmed: 24622687
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Am J Med Genet B Neuropsychiatr Genet. 2017 Oct;174(7):683-690
pubmed: 28556497
Am J Respir Crit Care Med. 2018 Jun 15;197(12):1552-1564
pubmed: 29509491
Nucleic Acids Res. 2013 Jan;41(Database issue):D1040-6
pubmed: 23203888
Biol Sex Differ. 2015 Dec 30;6:35
pubmed: 26719789
J Leukoc Biol. 2013 Mar;93(3):377-85
pubmed: 23258595
Eur J Immunol. 2017 Apr;47(4):615-628
pubmed: 28295214
J Virol. 2007 Apr;81(8):3852-65
pubmed: 17229681
Genet Epidemiol. 2010 Dec;34(8):816-34
pubmed: 21058334
Ann Intern Med. 2013 Feb 19;158(4):235-45
pubmed: 23420232
PLoS One. 2013 Nov 04;8(11):e77789
pubmed: 24223729
JAMA. 2000 Jul 26;284(4):450-6
pubmed: 10904508
J Autoimmun. 2018 May;89:139-148
pubmed: 29366602
BMC Bioinformatics. 2010 May 28;11:288
pubmed: 20509871
PLoS Genet. 2006 Dec;2(12):e190
pubmed: 17194218
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62
pubmed: 23817321
J Biochem. 2003 Oct;134(4):491-6
pubmed: 14607974
Immunogenetics. 2016 Jul;68(6-7):391-400
pubmed: 27142222
Hum Hered. 2012;73(1):18-25
pubmed: 22212296
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161

Auteurs

Candelaria Vergara (C)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.

Ana Valencia (A)

Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Universidad Pontificia Bolivariana, Medellín, Colombia.

Chloe L Thio (CL)

Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

James J Goedert (JJ)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Alessandra Mangia (A)

Liver Unit IRCCS "Casa Sollievo della Sofferenza," San Giovanni Rotondo, Italy.

Valeria Piazzolla (V)

Liver Unit IRCCS "Casa Sollievo della Sofferenza," San Giovanni Rotondo, Italy.

Eric Johnson (E)

RTI International, Research Triangle Park, North Carolina, USA.

Alex H Kral (AH)

RTI International, Research Triangle Park, North Carolina, USA.

Thomas R O'Brien (TR)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Shruti H Mehta (SH)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.

Gregory D Kirk (GD)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.
Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

Arthur Y Kim (AY)

Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Georg M Lauer (GM)

Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Raymond T Chung (RT)

Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Andrea L Cox (AL)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.

Marion G Peters (MG)

Division of Gastroenterology, Department of Medicine, School of Medicine, University of California, San Francisco, California, USA.

Salim I Khakoo (SI)

University of Southampton, Southampton General Hospital, Southampton, United Kingdom.

Laurent Alric (L)

Department of Internal Medicine and Digestive Diseases, CHU Rangueil, UMR 152 IRD, Toulouse 3 University, France.

Matthew E Cramp (ME)

South West Liver Unit, Plymouth, United Kingdom.

Sharyne M Donfield (SM)

Rho, Inc., Chapel Hill, North Carolina, USA.

Brian R Edlin (BR)

SUNY Downstate College of Medicine, Brooklyn, New York, USA.

Michael P Busch (MP)

University of California and Vitalant Research Institute, San Francisco, California, USA.

Graeme Alexander (G)

UCL Institute for Liver and Digestive Health, Royal Free Hospital, Hampstead, London, United Kingdom.

Hugo R Rosen (HR)

University of Colorado, Aurora, Colorado, USA.

Edward L Murphy (EL)

University of California and Vitalant Research Institute, San Francisco, California, USA.

Genevieve L Wojcik (GL)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.

Margaret A Taub (MA)

Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA.

David L Thomas (DL)

Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

Priya Duggal (P)

Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH